Kindred Healthcare (NYSE:KND) had its target price boosted by RBC Capital from $11.00 to $18.00 in a report issued on Tuesday, AnalystRatings.NET reports. They currently have a sector perform rating on the stock.
Kindred Healthcare (NYSE:KND) opened at 16.87 on Tuesday. Kindred Healthcare has a 52 week low of $9.75 and a 52 week high of $17.04. The stock’s 50-day moving average is $14.71 and its 200-day moving average is $14.17. The company’s market cap is $914.1 million.
Kindred Healthcare (NYSE:KND) last announced its earnings results on Tuesday, November 5th. The company reported $0.05 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.15 by $0.10. The company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $1.38 billion. During the same quarter in the previous year, the company posted $0.21 earnings per share. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. Analysts expect that Kindred Healthcare will post $1.07 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, December 9th. Stockholders of record on Monday, November 18th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.85%. The ex-dividend date of this dividend is Thursday, November 14th.
A number of other firms have also recently commented on KND. Analysts at Zacks downgraded shares of Kindred Healthcare from a neutral rating to an underperform rating in a research note to investors on Monday, November 11th. They now have a $13.10 price target on the stock. Separately, analysts at Barclays raised their price target on shares of Kindred Healthcare from $21.00 to $23.00 in a research note to investors on Wednesday, September 4th. They now have an overweight rating on the stock. Finally, analysts at Wells Fargo & Co. downgraded shares of Kindred Healthcare from a market perform rating to an underperform rating in a research note to investors on Wednesday, September 4th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of $17.52.
Kindred Healthcare, Inc is a healthcare services company that through its subsidiaries operates transitional care (NYSE:KND) hospitals, inpatient rehabilitation hospitals (IRFs), nursing and rehabilitation centers, assisted living facilities, a contract rehabilitation services business and a home health and hospice business across the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.